CHS (CYH) Q1 2026 Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 22 2026
0mins
Should l Buy CYH?
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CYH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CYH
Wall Street analysts forecast CYH stock price to rise
3 Analyst Rating
1 Buy
1 Hold
1 Sell
Hold
Current: 2.900
Low
2.00
Averages
3.67
High
5.00
Current: 2.900
Low
2.00
Averages
3.67
High
5.00
About CYH
Community Health Systems, Inc. is a healthcare company. The Company’s affiliates are providers of healthcare services, developing and operating healthcare delivery systems in approximately 33 distinct markets across 13 states. Its subsidiaries own or lease 64 affiliated hospitals with more than 9,000 beds and operate more than 900 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. It provides a range of general and specialized hospital healthcare services and outpatient services. Services provided through its hospitals and outpatient facilities include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. An integral part of providing these services is its network of affiliated physicians at its hospitals and affiliated businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
COMMUNITY HEALTH SYSTEMS INC.: BARCLAYS LOWERS TARGET PRICE TO $3 FROM $3.50
Company Overview: Community Health Systems, Inc. is a healthcare provider operating hospitals and healthcare facilities across the United States.
Stock Price Adjustment: Barclays has reduced the target price for Community Health Systems' stock from $3.50 to $3.00.
See More
Community Health Systems Launches $600 Million Bond Tender Offer
- Tender Offer Overview: Community Health Systems' wholly-owned subsidiary CHS/Community Health Systems, Inc. has initiated a tender offer of up to $600 million to purchase outstanding bonds, aiming to optimize its capital structure and enhance financial flexibility.
- Bond Details: The offer includes 4.750% Senior Secured Notes due 2031 with a tender cap of $350 million and 10.875% Senior Secured Notes due 2032 with a cap of $250 million, reflecting the company's focus on reducing debt costs.
- Early Tender Incentive: Holders who validly tender their notes by May 5, 2026, will receive an early tender payment of $50 per $1,000 of notes, designed to encourage early participation and increase the likelihood of a successful tender offer.
- Offer Timeline and Conditions: The tender offer will expire on May 20, 2026, requiring holders to tender their notes before this date, with purchases conducted based on acceptance priority levels to ensure effective debt management while optimizing capital allocation.
See More
Community Health Systems Reports Wider Q1 Loss
- Performance Decline: Community Health Systems (CYH) reported a wider adjusted loss in Q1, resulting in a 15.5% drop in share price, indicating significant financial pressure under current market conditions.
- Market Reaction: The disappointing earnings have raised investor concerns about the company's future profitability, potentially impacting its competitive position in the healthcare sector.
- Financial Challenges: The increased losses suggest issues with operational efficiency and cost control, indicating a need for the company to implement measures to improve its financial health.
- Strategic Adjustment Necessity: As market demands for healthcare services evolve, Community Health Systems may need to reassess its business strategy to adapt to the changing industry landscape.
See More
Community Health Systems Q1 2026 Earnings Call Insights
- Acquisition Expansion: Community Health Systems announced the acquisition of a majority stake in the Surgical Institute of Alabama, its largest acquisition since 2016, expected to close in Q2, aimed at enhancing surgical capabilities in core markets and improving overall business competitiveness.
- Declining Financial Performance: The first quarter adjusted EBITDA was $309 million, down 17.8% year-over-year, primarily impacted by recent hospital divestitures that resulted in a $50 million EBITDA drag, indicating pressure on the company's profitability.
- Cash Flow Strain: The first quarter operating cash flow was a negative $297 million compared to a positive $120 million in the prior year, largely due to delayed payments related to Medicaid and Medicare accounts receivable, reflecting challenges in liquidity management.
- Outlook Guidance: Despite facing challenges from demand softness and unfavorable payer mix, management maintained the 2026 adjusted EBITDA guidance range of $1.34 billion to $1.49 billion, indicating cautious optimism about future recovery.
See More
CHS (CYH) Q1 2026 Earnings Call Transcript
See More
Community Health Systems Misses Q1 Earnings Estimates, Shares Drop 11%
- Earnings Decline: Community Health Systems reported a Q1 EPS of -$0.43, which, despite a year-on-year increase, fell short of market expectations, resulting in an 11% drop in share price on Wednesday.
- Revenue Beat: The company achieved Q1 revenue of $2.96 billion, surpassing analyst consensus, indicating strong performance in certain areas despite multiple adverse factors impacting overall results.
- Future Guidance: Management affirmed its 2026 revenue outlook in the range of $11.6 billion to $12.0 billion, with adjusted EBITDA projected between $1.34 billion and $1.49 billion, reflecting strategic adjustments following asset divestitures.
- Cash Flow and Expenditures: The company anticipates full-year cash flow from operations of $600 million to $700 million and capital expenditures between $350 million and $400 million, demonstrating a cautious approach to future investments and operations.
See More
COMMUNITY HEALTH SYSTEMS INC.: BARCLAYS LOWERS TARGET PRICE TO $3 FROM $3.50
Company Overview: Community Health Systems, Inc. is a healthcare provider operating hospitals and healthcare facilities across the United States.
Stock Price Adjustment: Barclays has reduced the target price for Community Health Systems' stock from $3.50 to $3.00.
See More
Community Health Systems Launches $600 Million Bond Tender Offer
- Tender Offer Overview: Community Health Systems' wholly-owned subsidiary CHS/Community Health Systems, Inc. has initiated a tender offer of up to $600 million to purchase outstanding bonds, aiming to optimize its capital structure and enhance financial flexibility.
- Bond Details: The offer includes 4.750% Senior Secured Notes due 2031 with a tender cap of $350 million and 10.875% Senior Secured Notes due 2032 with a cap of $250 million, reflecting the company's focus on reducing debt costs.
- Early Tender Incentive: Holders who validly tender their notes by May 5, 2026, will receive an early tender payment of $50 per $1,000 of notes, designed to encourage early participation and increase the likelihood of a successful tender offer.
- Offer Timeline and Conditions: The tender offer will expire on May 20, 2026, requiring holders to tender their notes before this date, with purchases conducted based on acceptance priority levels to ensure effective debt management while optimizing capital allocation.
See More
Community Health Systems Reports Wider Q1 Loss
- Performance Decline: Community Health Systems (CYH) reported a wider adjusted loss in Q1, resulting in a 15.5% drop in share price, indicating significant financial pressure under current market conditions.
- Market Reaction: The disappointing earnings have raised investor concerns about the company's future profitability, potentially impacting its competitive position in the healthcare sector.
- Financial Challenges: The increased losses suggest issues with operational efficiency and cost control, indicating a need for the company to implement measures to improve its financial health.
- Strategic Adjustment Necessity: As market demands for healthcare services evolve, Community Health Systems may need to reassess its business strategy to adapt to the changing industry landscape.
See More
Community Health Systems Q1 2026 Earnings Call Insights
- Acquisition Expansion: Community Health Systems announced the acquisition of a majority stake in the Surgical Institute of Alabama, its largest acquisition since 2016, expected to close in Q2, aimed at enhancing surgical capabilities in core markets and improving overall business competitiveness.
- Declining Financial Performance: The first quarter adjusted EBITDA was $309 million, down 17.8% year-over-year, primarily impacted by recent hospital divestitures that resulted in a $50 million EBITDA drag, indicating pressure on the company's profitability.
- Cash Flow Strain: The first quarter operating cash flow was a negative $297 million compared to a positive $120 million in the prior year, largely due to delayed payments related to Medicaid and Medicare accounts receivable, reflecting challenges in liquidity management.
- Outlook Guidance: Despite facing challenges from demand softness and unfavorable payer mix, management maintained the 2026 adjusted EBITDA guidance range of $1.34 billion to $1.49 billion, indicating cautious optimism about future recovery.
See More
CHS (CYH) Q1 2026 Earnings Call Transcript
See More
Community Health Systems Misses Q1 Earnings Estimates, Shares Drop 11%
- Earnings Decline: Community Health Systems reported a Q1 EPS of -$0.43, which, despite a year-on-year increase, fell short of market expectations, resulting in an 11% drop in share price on Wednesday.
- Revenue Beat: The company achieved Q1 revenue of $2.96 billion, surpassing analyst consensus, indicating strong performance in certain areas despite multiple adverse factors impacting overall results.
- Future Guidance: Management affirmed its 2026 revenue outlook in the range of $11.6 billion to $12.0 billion, with adjusted EBITDA projected between $1.34 billion and $1.49 billion, reflecting strategic adjustments following asset divestitures.
- Cash Flow and Expenditures: The company anticipates full-year cash flow from operations of $600 million to $700 million and capital expenditures between $350 million and $400 million, demonstrating a cautious approach to future investments and operations.
See More
